Showing results (211-220 of 256) with videos related to

Sort By:
Pageof 26
Contemporary Clinical Trials|December 10, 2013
Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): clinical rationale and designGregory H Pelton, Howard Andrews, Steven P Roose, et al.
Journal of Alzheimer'S Disease : JAD|March 1, 2021
Olfactory Impairment Is Related to Tau Pathology and Neuroinflammation in Alzheimer's DiseaseJulia Klein, Xinyu Yan, Aubrey Johnson, et al.
Journal of Alzheimer'S Disease : JAD|October 31, 2017
Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive ImpairmentD P Devanand, Cody Lentz, Richard E Chunga, et al.
Archives of General Psychiatry|March 1, 1997
The course of psychopathologic features in mild to moderate Alzheimer diseaseD P Devanand, D M Jacobs, M X Tang, et al.
Plos One|July 30, 2015
Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic PopulationYian Gu, Qolamreza R Razlighi, Laura B Zahodne, et al.
Contemporary Clinical Trials|June 4, 2018
Lithium Treatment for Agitation in Alzheimer's disease (Lit-AD): Clinical rationale and study designD P Devanand, Jesse G Strickler, Edward D Huey, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 10, 2013
Comparative mortality risks of antipsychotic medications in community-dwelling older adultsT Gerhard, K Huybrechts, M Olfson, et al.
The New England Journal of Medicine|October 19, 2012
Relapse risk after discontinuation of risperidone in Alzheimer's diseaseD P Devanand, Jacobo Mintzer, Susan K Schultz, et al.
Psychiatry Research|October 12, 2010
Hydrocortisone responsiveness in Gulf War veterans with PTSD: effects on ACTH, declarative memory hippocampal [(18)F]FDG uptake on PETRachel Yehuda, Julia A Golier, Linda M Bierer, et al.
Journal of Alzheimer'S Disease : JAD|May 24, 2020
Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover StudyRachel Fremont, Masood Manoochehri, Nicole M Armstrong, et al.
Pageof 26